Skip to content
Homepage
Author:
Zealand Pharma
Posted Date:
August 19, 2026
Zealand Pharma – Transactions related to share buy-back program (week 33, 2026)
Zealand Pharma
August 19, 2026
Zealand Pharma Announces Financial Results for the First Half of 2026
Zealand Pharma
August 19, 2026
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
Zealand Pharma
August 19, 2026
Zealand Pharma – Transactions related to share buy-back program (week 32, 2026)
Zealand Pharma
August 18, 2026
Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results
Zealand Pharma
August 18, 2026
Zealand Pharma – Transactions related to share buy-back program (week 31, 2026)
Zealand Pharma
August 18, 2026
Zealand Pharma – Transactions related to share buy-back program (week 30, 2026)
Zealand Pharma
August 17, 2026
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma
July 20, 2026
Zealand Pharma: Transactions related to share buy-back program (week 29, 2026)
Zealand Pharma
July 20, 2026
Zealand Pharma – Transactions related to share buy-back program (week 28, 2026)
Zealand Pharma
July 13, 2026
1
2
3
Next
